谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Expanded Biomarker Analysis of an International, Open-Label Phase 2 Study of Regorafenib Plus Pembrolizumab in Patients with Advanced Hepatocellular Carcinoma (HCC) Previously Treated with Immune Checkpoint Inhibitors (ICI).

Anthony B. El-Khoueiry, David Balli,Jean-Frédéric Blanc,Olivier Rosmorduc,Thomas Decaens,Philippe Mathurin,Philippe Merle,Farshid Dayyani,Gianluca Masi,Tiziana Pressiani, Peter Robert Galle,Ken Hatogai,Udo Mueller, Stacey Anastasia Kalambakas,Anke Weispfenning, Yuko Ishii,Mohamed Bouattour

Journal of Clinical Oncology（2025）

引用 0|浏览4
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要